| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.23 | 1e-05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |